Stock listing

A2H63F Stock Price, News, Filings & Events — Spero Therapeutics, Inc.

Selected listing: A2H63F · LSX · EUR · DE

The selected listing A2H63F:LSX represents Spero Therapeutics, Inc., a biopharmaceutical company focused on developing innovative treatments for bacterial infections. The company is advancing its pipeline of therapies aimed at addressing unmet medical needs in infectious diseases. Recent news includes updates on clinical trials and regulatory filings that highlight Spero's commitment to bringing new solutions to market. Investors can stay informed about upcoming events and market developments related to Spero's initiatives.

A2H63F:LSXEURDEUpdated July 24, 2026
Spero Therapeutics, Inc. logo
Ticker
A2H63F:LSX
Asset type
Stock
Market cap
$68.9M
Sector
Health Technology
Industry
Biotechnology
Exchange
LSX
Currency
EUR

Spero Therapeutics, Inc. A2H63F:LSX stock context

The selected listing A2H63F:LSX represents Spero Therapeutics, Inc., a biopharmaceutical company focused on developing innovative treatments for bacterial infections. The company is advancing its pipeline of therapies aimed at addressing unmet medical needs in infectious diseases. Recent news includes updates on clinical trials and regulatory filings that highlight Spero's commitment to bringing new solutions to market. Investors can stay informed about upcoming events and market developments related to Spero's initiatives.

Research Spero Therapeutics, Inc.

Alternate listings